GWAG
IMGN

Garrett Wealth Advisory Group’s Immunogen Inc IMGN Stock Holding History

Garrett Wealth Advisory Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-105
Closed -$254 – 673
2019
Q3 		$254 Buy
+105
New +$279 ﹤0.01% 772

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Garrett Wealth Advisory Group's IMGN Position: Q4 2019 in Review

Garrett Wealth Advisory Group sold out of Immunogen Inc (IMGN) in Q4 2019, closing a stake of 105 shares — an estimated $254 sold.

Garrett Wealth Advisory Group first reported a position in IMGN in Q3 2019 and held it in 1 quarter. The position peaked at $254 in Q3 2019. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

  • Garrett Wealth Advisory Group reported no remaining Immunogen Inc position as of Q4 2019 after selling out during the quarter.
  • Garrett Wealth Advisory Group sold 105 Immunogen Inc shares in Q4 2019, an estimated $254.
  • Garrett Wealth Advisory Group first reported a position in Immunogen Inc in Q3 2019 and held it in 1 quarter.
  • Garrett Wealth Advisory Group's Immunogen Inc position peaked at $254 in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Garrett Wealth Advisory Group's 13F filing for Q4 2019, filed 28 Jan 2020.